Cargando…

Isoprenoid-chained lipid EROCOC(17+4): a new matrix for membrane protein crystallization and a crystal delivery medium in serial femtosecond crystallography

In meso crystallization of membrane proteins relies on the use of lipids capable of forming a lipidic cubic phase (LCP). However, almost all previous crystallization trials have used monoacylglycerols, with 1-(cis-9-octadecanoyl)-rac-glycerol (MO) being the most widely used lipid. We now report that...

Descripción completa

Detalles Bibliográficos
Autores principales: Ihara, Kentaro, Hato, Masakatsu, Nakane, Takanori, Yamashita, Keitaro, Kimura-Someya, Tomomi, Hosaka, Toshiaki, Ishizuka-Katsura, Yoshiko, Tanaka, Rie, Tanaka, Tomoyuki, Sugahara, Michihiro, Hirata, Kunio, Yamamoto, Masaki, Nureki, Osamu, Tono, Kensuke, Nango, Eriko, Iwata, So, Shirouzu, Mikako
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652841/
https://www.ncbi.nlm.nih.gov/pubmed/33168855
http://dx.doi.org/10.1038/s41598-020-76277-x
_version_ 1783607777164263424
author Ihara, Kentaro
Hato, Masakatsu
Nakane, Takanori
Yamashita, Keitaro
Kimura-Someya, Tomomi
Hosaka, Toshiaki
Ishizuka-Katsura, Yoshiko
Tanaka, Rie
Tanaka, Tomoyuki
Sugahara, Michihiro
Hirata, Kunio
Yamamoto, Masaki
Nureki, Osamu
Tono, Kensuke
Nango, Eriko
Iwata, So
Shirouzu, Mikako
author_facet Ihara, Kentaro
Hato, Masakatsu
Nakane, Takanori
Yamashita, Keitaro
Kimura-Someya, Tomomi
Hosaka, Toshiaki
Ishizuka-Katsura, Yoshiko
Tanaka, Rie
Tanaka, Tomoyuki
Sugahara, Michihiro
Hirata, Kunio
Yamamoto, Masaki
Nureki, Osamu
Tono, Kensuke
Nango, Eriko
Iwata, So
Shirouzu, Mikako
author_sort Ihara, Kentaro
collection PubMed
description In meso crystallization of membrane proteins relies on the use of lipids capable of forming a lipidic cubic phase (LCP). However, almost all previous crystallization trials have used monoacylglycerols, with 1-(cis-9-octadecanoyl)-rac-glycerol (MO) being the most widely used lipid. We now report that EROCOC(17+4) mixed with 10% (w/w) cholesterol (Fig. 1) serves as a new matrix for crystallization and a crystal delivery medium in the serial femtosecond crystallography of Adenosine A(2A) receptor (A(2A)R). The structures of EROCOC(17+4)-matrix grown A(2A)R crystals were determined at 2.0 Å resolution by serial synchrotron rotation crystallography at a cryogenic temperature, and at 1.8 Å by LCP-serial femtosecond crystallography, using an X-ray free-electron laser at 4 and 20 °C sample temperatures, and are comparable to the structure of the MO-matrix grown A(2A)R crystal (PDB ID: 4EIY). Moreover, X-ray scattering measurements indicated that the EROCOC(17+4)/water system did not form the crystalline L(C) phase at least down to − 20 °C, in marked contrast to the equilibrium MO/water system, which transforms into the crystalline L(C) phase below about 17 °C. As the L(C) phase formation within the LCP-matrix causes difficulties in protein crystallography experiments in meso, this feature of EROCOC(17+4) will expand the utility of the in meso method.
format Online
Article
Text
id pubmed-7652841
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-76528412020-11-12 Isoprenoid-chained lipid EROCOC(17+4): a new matrix for membrane protein crystallization and a crystal delivery medium in serial femtosecond crystallography Ihara, Kentaro Hato, Masakatsu Nakane, Takanori Yamashita, Keitaro Kimura-Someya, Tomomi Hosaka, Toshiaki Ishizuka-Katsura, Yoshiko Tanaka, Rie Tanaka, Tomoyuki Sugahara, Michihiro Hirata, Kunio Yamamoto, Masaki Nureki, Osamu Tono, Kensuke Nango, Eriko Iwata, So Shirouzu, Mikako Sci Rep Article In meso crystallization of membrane proteins relies on the use of lipids capable of forming a lipidic cubic phase (LCP). However, almost all previous crystallization trials have used monoacylglycerols, with 1-(cis-9-octadecanoyl)-rac-glycerol (MO) being the most widely used lipid. We now report that EROCOC(17+4) mixed with 10% (w/w) cholesterol (Fig. 1) serves as a new matrix for crystallization and a crystal delivery medium in the serial femtosecond crystallography of Adenosine A(2A) receptor (A(2A)R). The structures of EROCOC(17+4)-matrix grown A(2A)R crystals were determined at 2.0 Å resolution by serial synchrotron rotation crystallography at a cryogenic temperature, and at 1.8 Å by LCP-serial femtosecond crystallography, using an X-ray free-electron laser at 4 and 20 °C sample temperatures, and are comparable to the structure of the MO-matrix grown A(2A)R crystal (PDB ID: 4EIY). Moreover, X-ray scattering measurements indicated that the EROCOC(17+4)/water system did not form the crystalline L(C) phase at least down to − 20 °C, in marked contrast to the equilibrium MO/water system, which transforms into the crystalline L(C) phase below about 17 °C. As the L(C) phase formation within the LCP-matrix causes difficulties in protein crystallography experiments in meso, this feature of EROCOC(17+4) will expand the utility of the in meso method. Nature Publishing Group UK 2020-11-09 /pmc/articles/PMC7652841/ /pubmed/33168855 http://dx.doi.org/10.1038/s41598-020-76277-x Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Ihara, Kentaro
Hato, Masakatsu
Nakane, Takanori
Yamashita, Keitaro
Kimura-Someya, Tomomi
Hosaka, Toshiaki
Ishizuka-Katsura, Yoshiko
Tanaka, Rie
Tanaka, Tomoyuki
Sugahara, Michihiro
Hirata, Kunio
Yamamoto, Masaki
Nureki, Osamu
Tono, Kensuke
Nango, Eriko
Iwata, So
Shirouzu, Mikako
Isoprenoid-chained lipid EROCOC(17+4): a new matrix for membrane protein crystallization and a crystal delivery medium in serial femtosecond crystallography
title Isoprenoid-chained lipid EROCOC(17+4): a new matrix for membrane protein crystallization and a crystal delivery medium in serial femtosecond crystallography
title_full Isoprenoid-chained lipid EROCOC(17+4): a new matrix for membrane protein crystallization and a crystal delivery medium in serial femtosecond crystallography
title_fullStr Isoprenoid-chained lipid EROCOC(17+4): a new matrix for membrane protein crystallization and a crystal delivery medium in serial femtosecond crystallography
title_full_unstemmed Isoprenoid-chained lipid EROCOC(17+4): a new matrix for membrane protein crystallization and a crystal delivery medium in serial femtosecond crystallography
title_short Isoprenoid-chained lipid EROCOC(17+4): a new matrix for membrane protein crystallization and a crystal delivery medium in serial femtosecond crystallography
title_sort isoprenoid-chained lipid erococ(17+4): a new matrix for membrane protein crystallization and a crystal delivery medium in serial femtosecond crystallography
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652841/
https://www.ncbi.nlm.nih.gov/pubmed/33168855
http://dx.doi.org/10.1038/s41598-020-76277-x
work_keys_str_mv AT iharakentaro isoprenoidchainedlipiderococ174anewmatrixformembraneproteincrystallizationandacrystaldeliverymediuminserialfemtosecondcrystallography
AT hatomasakatsu isoprenoidchainedlipiderococ174anewmatrixformembraneproteincrystallizationandacrystaldeliverymediuminserialfemtosecondcrystallography
AT nakanetakanori isoprenoidchainedlipiderococ174anewmatrixformembraneproteincrystallizationandacrystaldeliverymediuminserialfemtosecondcrystallography
AT yamashitakeitaro isoprenoidchainedlipiderococ174anewmatrixformembraneproteincrystallizationandacrystaldeliverymediuminserialfemtosecondcrystallography
AT kimurasomeyatomomi isoprenoidchainedlipiderococ174anewmatrixformembraneproteincrystallizationandacrystaldeliverymediuminserialfemtosecondcrystallography
AT hosakatoshiaki isoprenoidchainedlipiderococ174anewmatrixformembraneproteincrystallizationandacrystaldeliverymediuminserialfemtosecondcrystallography
AT ishizukakatsurayoshiko isoprenoidchainedlipiderococ174anewmatrixformembraneproteincrystallizationandacrystaldeliverymediuminserialfemtosecondcrystallography
AT tanakarie isoprenoidchainedlipiderococ174anewmatrixformembraneproteincrystallizationandacrystaldeliverymediuminserialfemtosecondcrystallography
AT tanakatomoyuki isoprenoidchainedlipiderococ174anewmatrixformembraneproteincrystallizationandacrystaldeliverymediuminserialfemtosecondcrystallography
AT sugaharamichihiro isoprenoidchainedlipiderococ174anewmatrixformembraneproteincrystallizationandacrystaldeliverymediuminserialfemtosecondcrystallography
AT hiratakunio isoprenoidchainedlipiderococ174anewmatrixformembraneproteincrystallizationandacrystaldeliverymediuminserialfemtosecondcrystallography
AT yamamotomasaki isoprenoidchainedlipiderococ174anewmatrixformembraneproteincrystallizationandacrystaldeliverymediuminserialfemtosecondcrystallography
AT nurekiosamu isoprenoidchainedlipiderococ174anewmatrixformembraneproteincrystallizationandacrystaldeliverymediuminserialfemtosecondcrystallography
AT tonokensuke isoprenoidchainedlipiderococ174anewmatrixformembraneproteincrystallizationandacrystaldeliverymediuminserialfemtosecondcrystallography
AT nangoeriko isoprenoidchainedlipiderococ174anewmatrixformembraneproteincrystallizationandacrystaldeliverymediuminserialfemtosecondcrystallography
AT iwataso isoprenoidchainedlipiderococ174anewmatrixformembraneproteincrystallizationandacrystaldeliverymediuminserialfemtosecondcrystallography
AT shirouzumikako isoprenoidchainedlipiderococ174anewmatrixformembraneproteincrystallizationandacrystaldeliverymediuminserialfemtosecondcrystallography